Retention of coagulation factors in plasma frozen after extended holding at 1-6°C

Janis F. Smith, Paul Michael Ness, Gary Moroff, Naomi L C Luban

Research output: Contribution to journalArticle

Abstract

Background and Objectives: The ability to use plasma, isolated from units of whole blood and frozen within 24 h of phlebotomy, as a substitute for plasma frozen within 8 h of phlebotomy would have several advantages for blood centers. It should provide increased flexibility pertaining to the freezing of plasma for clinical use. We have conducted studies to assess the influence of an extended holding time for separated plasma, prior to freezing, on the retention of coagulation factor activity. Study Design and Methods: Freshly harvested plasma from each of 10 units of CPD-whole blood was divided into four equal aliquots. These aliquots were held in plastic packs at 1-6°C for a total of 0, 8, 15 and 24 h. Subsequently, the plasma aliquots were frozen rapidly and stored at -20°C for 4 months. The thawed plasma was tested for coagulant factors V and IX, factor VIII coagulant activity (factor VIII:C), von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor of von Willebrand factor. Results: The levels of factor V, factor vWF:Ag, factor IX and ristocetin cofactor were not influenced by holding the plasma for up to 24 h prior to freezing. Factor VIII:C activity was reduced with extended holding at 1-6°C; the percentage at time zero activity was 75.9 ± 2.4% for samples frozen immediately after a 24-hour period. Conclusions: The data indicate that coagulation factor properties of harvested plasma are retained except for factor VIII for at least 24 h prior to freezing. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish (US)
Pages (from-to)28-30
Number of pages3
JournalVox Sanguinis
Volume78
Issue number1
StatePublished - Feb 2000
Externally publishedYes

Fingerprint

Blood Coagulation Factors
von Willebrand Factor
Freezing
Factor VIII
Coagulants
Factor IX
Phlebotomy
Factor V
Plasma Substitutes
Plastics

ASJC Scopus subject areas

  • Hematology

Cite this

Retention of coagulation factors in plasma frozen after extended holding at 1-6°C. / Smith, Janis F.; Ness, Paul Michael; Moroff, Gary; Luban, Naomi L C.

In: Vox Sanguinis, Vol. 78, No. 1, 02.2000, p. 28-30.

Research output: Contribution to journalArticle

Smith, JF, Ness, PM, Moroff, G & Luban, NLC 2000, 'Retention of coagulation factors in plasma frozen after extended holding at 1-6°C', Vox Sanguinis, vol. 78, no. 1, pp. 28-30.
Smith, Janis F. ; Ness, Paul Michael ; Moroff, Gary ; Luban, Naomi L C. / Retention of coagulation factors in plasma frozen after extended holding at 1-6°C. In: Vox Sanguinis. 2000 ; Vol. 78, No. 1. pp. 28-30.
@article{43da29a232de4e0cbff74798ab64daf6,
title = "Retention of coagulation factors in plasma frozen after extended holding at 1-6°C",
abstract = "Background and Objectives: The ability to use plasma, isolated from units of whole blood and frozen within 24 h of phlebotomy, as a substitute for plasma frozen within 8 h of phlebotomy would have several advantages for blood centers. It should provide increased flexibility pertaining to the freezing of plasma for clinical use. We have conducted studies to assess the influence of an extended holding time for separated plasma, prior to freezing, on the retention of coagulation factor activity. Study Design and Methods: Freshly harvested plasma from each of 10 units of CPD-whole blood was divided into four equal aliquots. These aliquots were held in plastic packs at 1-6°C for a total of 0, 8, 15 and 24 h. Subsequently, the plasma aliquots were frozen rapidly and stored at -20°C for 4 months. The thawed plasma was tested for coagulant factors V and IX, factor VIII coagulant activity (factor VIII:C), von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor of von Willebrand factor. Results: The levels of factor V, factor vWF:Ag, factor IX and ristocetin cofactor were not influenced by holding the plasma for up to 24 h prior to freezing. Factor VIII:C activity was reduced with extended holding at 1-6°C; the percentage at time zero activity was 75.9 ± 2.4{\%} for samples frozen immediately after a 24-hour period. Conclusions: The data indicate that coagulation factor properties of harvested plasma are retained except for factor VIII for at least 24 h prior to freezing. Copyright (C) 2000 S. Karger AG, Basel.",
author = "Smith, {Janis F.} and Ness, {Paul Michael} and Gary Moroff and Luban, {Naomi L C}",
year = "2000",
month = "2",
language = "English (US)",
volume = "78",
pages = "28--30",
journal = "Vox Sanguinis",
issn = "0042-9007",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Retention of coagulation factors in plasma frozen after extended holding at 1-6°C

AU - Smith, Janis F.

AU - Ness, Paul Michael

AU - Moroff, Gary

AU - Luban, Naomi L C

PY - 2000/2

Y1 - 2000/2

N2 - Background and Objectives: The ability to use plasma, isolated from units of whole blood and frozen within 24 h of phlebotomy, as a substitute for plasma frozen within 8 h of phlebotomy would have several advantages for blood centers. It should provide increased flexibility pertaining to the freezing of plasma for clinical use. We have conducted studies to assess the influence of an extended holding time for separated plasma, prior to freezing, on the retention of coagulation factor activity. Study Design and Methods: Freshly harvested plasma from each of 10 units of CPD-whole blood was divided into four equal aliquots. These aliquots were held in plastic packs at 1-6°C for a total of 0, 8, 15 and 24 h. Subsequently, the plasma aliquots were frozen rapidly and stored at -20°C for 4 months. The thawed plasma was tested for coagulant factors V and IX, factor VIII coagulant activity (factor VIII:C), von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor of von Willebrand factor. Results: The levels of factor V, factor vWF:Ag, factor IX and ristocetin cofactor were not influenced by holding the plasma for up to 24 h prior to freezing. Factor VIII:C activity was reduced with extended holding at 1-6°C; the percentage at time zero activity was 75.9 ± 2.4% for samples frozen immediately after a 24-hour period. Conclusions: The data indicate that coagulation factor properties of harvested plasma are retained except for factor VIII for at least 24 h prior to freezing. Copyright (C) 2000 S. Karger AG, Basel.

AB - Background and Objectives: The ability to use plasma, isolated from units of whole blood and frozen within 24 h of phlebotomy, as a substitute for plasma frozen within 8 h of phlebotomy would have several advantages for blood centers. It should provide increased flexibility pertaining to the freezing of plasma for clinical use. We have conducted studies to assess the influence of an extended holding time for separated plasma, prior to freezing, on the retention of coagulation factor activity. Study Design and Methods: Freshly harvested plasma from each of 10 units of CPD-whole blood was divided into four equal aliquots. These aliquots were held in plastic packs at 1-6°C for a total of 0, 8, 15 and 24 h. Subsequently, the plasma aliquots were frozen rapidly and stored at -20°C for 4 months. The thawed plasma was tested for coagulant factors V and IX, factor VIII coagulant activity (factor VIII:C), von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor of von Willebrand factor. Results: The levels of factor V, factor vWF:Ag, factor IX and ristocetin cofactor were not influenced by holding the plasma for up to 24 h prior to freezing. Factor VIII:C activity was reduced with extended holding at 1-6°C; the percentage at time zero activity was 75.9 ± 2.4% for samples frozen immediately after a 24-hour period. Conclusions: The data indicate that coagulation factor properties of harvested plasma are retained except for factor VIII for at least 24 h prior to freezing. Copyright (C) 2000 S. Karger AG, Basel.

UR - http://www.scopus.com/inward/record.url?scp=0034097236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034097236&partnerID=8YFLogxK

M3 - Article

C2 - 10729808

AN - SCOPUS:0034097236

VL - 78

SP - 28

EP - 30

JO - Vox Sanguinis

JF - Vox Sanguinis

SN - 0042-9007

IS - 1

ER -